AEON Biopharma | 3: Initial statement of beneficial ownership of securities-Officer Sy Jennifer
AEON Biopharma | 3: Initial statement of beneficial ownership of securities-Director Park Seongsoo
AEON Biopharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner Daewoong Co., Ltd
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Daewoong Co., Ltd
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Daewoong Co., Ltd
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Thunen Shelley B
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-Director PALMISANO ROBERT J
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Forth Marc
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Oh Chad
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-Director FISCHER JOST
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Carter Eric G
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Wilson Alexander Blair
AEON Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Polar Asset Management Partners Inc.(9.9%)
AEON Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Empyrean Capital Partners, LP(0%),Amos Meron(0%)
AEON Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Strathspey Crown Holdings Group, LLC(5.47%)
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Thunen Shelley B
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-Director PALMISANO ROBERT J
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-Director FISCHER JOST
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Carter Eric G
AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Strathspey Crown Holdings Group, LLC
No Data